Literature DB >> 30054677

[Imaging in individualized uro-oncology].

J Bründl1, J Breyer2, M Burger2.   

Abstract

The recent introduction of new diagnostic techniques has revolutionized uro-oncolgy. In addition to multiparametric magnetic resonance imaging (mpMRI), prostate-specific membrane antigen positron-emission tomography (PSMA-PET) plays an increasingly import role in daily practice. The introduction of three-dimensional (3D) printing technologies in the context of robot-assisted uro-oncological surgery represents a first step towards individualized 3D imaging. In the era of immunotherapy, imaging is challenged by new diagnostic criteria (iRECIST) and immune-related adverse effects.

Keywords:  3D-Printing; Multiparametric MRI; PSMA-PET; PSMA-guided surgery; Radiomics; iRECIST

Mesh：

Substances：

Year:  2018        PMID： 30054677     DOI： 10.1007/s00120-018-0729-9

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  44 in total

Review 1.  Imaging response assessment of immunotherapy in patients with renal cell and urothelial carcinoma.

Authors:  Jakob Weiss; Mike Notohamiprodjo; Jens Bedke; Konstantin Nikolaou; Sascha Kaufmann
Journal:  Curr Opin Urol       Date:  2018-01       Impact factor: 2.309

2.  One-Stop-Shop Whole-Body 68Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer.

Authors:  Mark Thalgott; Charlotte Düwel; Isabel Rauscher; Matthias M Heck; Bernhard Haller; Andrei Gafita; Jürgen E Gschwend; Markus Schwaiger; Tobias Maurer; Matthias Eiber
Journal:  J Nucl Med       Date:  2018-05-24       Impact factor: 10.057

3.  Evaluation of three-dimensional printing for laparoscopic partial nephrectomy of renal tumors: a preliminary report.

Authors:  Yi Zhang; Hong-wei Ge; Ning-chen Li; Cheng-fan Yu; Hong-feng Guo; Shi-hua Jin; Jin-shun Liu; Yan-qun Na
Journal:  World J Urol       Date:  2015-04-05       Impact factor: 4.226

4.  Declining incidence of benign lesions among small renal masses treated with surgery: Effect of diagnostic tests for characterization.

Authors:  Sangjun Yoo; Dalsan You; Cheryn Song; Bumsik Hong; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn; In Gab Jeong
Journal:  Urol Oncol       Date:  2018-06-01       Impact factor: 3.498

Review 5.  Intraoperative Imaging Techniques to Support Complete Tumor Resection in Partial Nephrectomy.

Authors:  Marlène C H Hekman; Mark Rijpkema; Johan F Langenhuijsen; Otto C Boerman; Egbert Oosterwijk; Peter F A Mulders
Journal:  Eur Urol Focus       Date:  2017-05-12

Review 6.  The potential of 3D printing in urological research and patient care.

Authors:  Marc Colaco; Daniel A Igel; Anthony Atala
Journal:  Nat Rev Urol       Date:  2018-02-06       Impact factor: 14.432

7.  Utility of patient-specific silicone renal models for planning and rehearsal of complex tumour resections prior to robot-assisted laparoscopic partial nephrectomy.

Authors:  Friedrich-Carl von Rundstedt; Jason M Scovell; Smriti Agrawal; Jacques Zaneveld; Richard E Link
Journal:  BJU Int       Date:  2016-12-10       Impact factor: 5.588

8.  Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.

Authors:  Tobias Maurer; Gregor Weirich; Margret Schottelius; Martina Weineisen; Benjamin Frisch; Asli Okur; Hubert Kübler; Mark Thalgott; Nassir Navab; Markus Schwaiger; Hans-Jürgen Wester; Jürgen E Gschwend; Matthias Eiber
Journal:  Eur Urol       Date:  2015-05-06       Impact factor: 20.096

9.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

Review 10.  [Radiological response assessment of modern immunotherapy using iRECIST].

Authors:  T Persigehl; T D Poeppel; O Sedlaczek
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.